| 发明名称 |
Pharmaceutical compositions |
| 摘要 |
The present invention relates to pharmaceutical compositions for sustained release comprising a water soluble salt of the HMG-CoA reductase inhibitor fluvastatin as active ingredient, said composition being selected from the group comprising matrix formulations, diffusion-controlled membrane coated formulations; and combinations thereof.
|
| 申请公布号 |
US2004132814(A1) |
申请公布日期 |
2004.07.08 |
| 申请号 |
US20030738196 |
申请日期 |
2003.12.17 |
| 申请人 |
LOEFROTH JAN-ERIK;OEDMAN JONAS |
发明人 |
LOEFROTH JAN-ERIK;OEDMAN JONAS |
| 分类号 |
A61K9/20;A61K9/22;A61K9/48;A61K9/50;A61K9/52;A61K31/19;A61K31/404;A61K47/30;A61K47/38;A61P3/04;(IPC1-7):A61K31/225;A61K9/14 |
主分类号 |
A61K9/20 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
